Completed PHASE1 INTERVENTIONAL 2-arm
NCT05926245
Topical Absorption of Glutathione-cyclodextrin Complex in Healthy Human Subjects Improves Immune Response Against Mycobacterium Infection
Sponsor: Western University of Health Sciences
Conditions
Glutathione-cyclodextrin Complex Absorption
Interventions
Glutaryl Solution Placebo Solution
Updated 3 times since 2023 Last updated: Jun 26, 2023 Started: Jul 11, 2022 Primary completion: Aug 2, 2022 Completion: Dec 14, 2022
This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.
This PHASE1 trial investigates Glutathione-cyclodextrin Complex Absorption and is currently completed. Western University of Health Sciences leads this study, which shows 3 recorded versions since 2022 — indicating limited longitudinal coverage. The change history captured here reflects the iterative nature of clinical trial conduct.
Status Flow
Change History
3 versions recorded-
Sep 2024 — Present [monthly]
Completed PHASE1
-
Jul 2024 — Sep 2024 [monthly]
Completed PHASE1
-
Aug 2023 — Jul 2024 [monthly]
Completed PHASE1
First recorded
Jul 2022
Trial started
Per CT.gov start date — pre-dates our first snapshot
Eligibility Summary
No eligibility information available.
Contact Information
Sponsor contact:
- Western University of Health Sciences
Data source: Western University of Health Sciences
For direct contact, visit the study record on ClinicalTrials.gov .